Reset filters
  • 7 July 2006

Take home messages from the 15th HIV Resistance Workshop

Read the article
  • 6 July 2006

15th HIV Resistance Workshop: resistance to Kaletra monotherapy

Read the article
  • 6 July 2006

15th HIV Resistance Workshop: can new Tibotec NNRTI overcome cross-class resistance?

Read the article
  • 4 July 2006

Kaletra receives EU marketing approval; developing countries registration 'moving forward'

Read the article
  • 8 June 2006

Genetic testing can predict who is at risk of abacavir hypersensitivity

Read the article
  • 7 June 2006

Patients taking three-drug NRTI therapy should switch, even if they have durable virological suppression

Read the article
  • 7 April 2006

BHIVA: Kaletra monotherapy has benefits in clinical practice for highly treatment-experienced

Read the article
  • 3 April 2006

BHIVA: UK HIV patients remained on first combination for almost seven years during early-HAART era

Read the article
  • 15 March 2006

Atazanavir/ritonavir as potent over two years as Kaletra, but has better side-effects profile

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.